The last time Pharm Exec covered Valeant Pharmaceuticals, it was in 2005, and things were looking good for the company. It had a new name, and a sleek new organization, lighter than the old by 8,000 employees. New CEO Timothy Tyson had created a talented and enthusiastic new management team. A new strategy was in […]
-
Pharma News- Pharma CEOs Expound on Industry Change
- New Educational Program to Boost PR Compliance
- New Act to Protect Patients Could Cripple Preemption
- Zinc Finger Proteins Put Personalized HIV Therapy Within Reach; Penn Researchers Modify T-Cell Receptor Gene to Develop New Type of AIDS Treatment
- State and Territorial Health Officials Take Critical Steps to Protect Vulnerable Populations; Association Releases Pandemic Preparedness Guidance
Blogroll